| Value | ₹12.40 Cr |
|---|
NSE filing, NSE: LAURUSLABS. Summary written from the filing by ALFA Finder's alert engine.
Laurus Labs Ltd: key numbers
- Share price
- ₹2,170.00
- Market cap
- ₹1,17,248 Cr
- Revenue (annual)
- ₹6,813 Cr
- Net profit (annual)
- ₹888.8 Cr
- P/E (TTM)
- 107.2×Sector 46.1×
- Promoter holding
- 27.47%+0.00% QoQ
- FII holding
- 30.84%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Laurus Labs Ltd
All →Laurus Labs Investor Presentation: Key Takeaways
Q2/H1 FY27: H1 revenue ₹4,233 Cr (+31%), EBITDA ₹1,406 Cr (33.2% margin), PAT ₹809 Cr (+126%). CDMO-led growth; ₹3,000 Cr+ capex planned FY27-28.
Laurus Labs Dividend
Laurus Labs approved a Re. 1.00 per share interim dividend for FY 2026-27. Record date is November 6, 2026; payment on or after November 19, 2026.
Laurus Labs Management Change
Laurus Labs appointed Mr. Kundan Kumar Jha as Joint Company Secretary effective November 1, 2026, following Board approval. The KMP appointment advances the company's succession planning process.
Laurus Labs Acquisition Worth ₹32.5 Cr
Laurus Labs approved acquiring 52% of SI & C Resins for Rs. 32.50 Crore. The acquisition makes SI&C a subsidiary for peptide resin manufacturing.
- Value
- ₹32.50 Cr
Laurus Labs Acquisition Worth ₹35.63 Cr
Laurus Labs approved buying 60% of Canada-based CRO Galenvs Sciences for USD 3.75 million (₹35.63 Cr). The deal adds an oligonucleotide R&D arm and North American presence.
- Value
- ₹35.63 Cr
Laurus Labs Q2 FY27 Results: Net Profit ₹436.2 Cr, Up 124.3% YoY
Laurus Labs Ltd reported revenue from operations of ₹2,206 Cr (+33.4% YoY) and net profit of ₹436.2 Cr (+124.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹436.2 Cr · +124.3% YoY
Other employee stock options announcements
All →Tata Consumer Products Employee Stock Options
Tata Consumer approved allotment of 551 equity shares against exercise of ESOPs under its 2021 Long Term Incentive Scheme. Paid-up capital rose by 551 shares of Re.1 each.
Ramkrishna Forgings Employee Stock Options
Ramkrishna Forgings granted 5,50,000 ESOPs at Rs.598 per option under its 2023 scheme to eligible employees. Vesting runs over four tranches of 25% each across four years.
IIFL Capital Services Employee Stock Options
IIFL Capital Services granted 29,713 ESOPs and allotted 180,499 shares on exercise under its 2018 ESOS scheme. The equity base rose to 315,532,512 shares of ₹2 each.
Brigade Enterprises Employee Stock Options
Brigade Enterprises approved allotment of 39,094 ESOP shares and granted 1,484,344 options under its new 2026 ESOP scheme. Paid-up capital rose by Rs. 39.1 lakh due to the allotment.
SBI Cards and Payment Services Employee Stock Options
SBI Cards allotted 5,560 equity shares on exercise of options under its ESOP Plan 2019 and 2023. Paid-up capital rose to Rs.9,516.43 Crore post-allotment.
Restaurant Brands Asia Employee Stock Options
Restaurant Brands Asia allotted 9,259 equity shares under its ESOP Scheme 2015. Paid-up capital rose to 71,22,27,588 shares.